tirzepatide and bipolar Brenipatide vs Tirzepatide: 2026 Comparison Mounjaro and Bipolar Disorder: Safety,

Here are the health stories we're watching in 2025 Wegovy is a weight-loss drug

Renal complications : In rare cases, severe gastrointestinal side effects may lead to dehydration, which could affect kidney function

[18] [16] Patients should also seek medical advice if they experience symptoms suggestive of severe gastroparesis (delayed gastric emptying), including persistent bloating, early satiety, recurrent vomiting of undigested food, and unintentional weight loss

In September 2023, the FDA classified BPC-157 as a Category 2 bulk substance, prohibiting its inclusion in compounded medications

A systematic review of randomised controlled trials

For patients considering alternatives altogether, the peptide safety guide covers the broader landscape